Collegium Pharmaceutical, Inc.
COLL
$47.85
$0.340.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 237.51% | -38.88% | -91.28% | -60.75% | -54.76% |
| Total Depreciation and Amortization | 35.35% | 59.61% | 59.63% | 59.35% | 12.37% |
| Total Amortization of Deferred Charges | 11.18% | -15.52% | -23.20% | -27.46% | -43.13% |
| Total Other Non-Cash Items | -190.62% | -35.41% | 309.52% | -143.41% | -49.53% |
| Change in Net Operating Assets | 86.70% | -164.50% | -179.63% | 899.67% | -824.44% |
| Cash from Operations | 971.63% | 7.48% | -10.56% | 15.42% | -112.16% |
| Capital Expenditure | 22.95% | 75.93% | -40.49% | -247.56% | -275.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -263.03% | 67.00% | 49.42% | 55.11% | 600.90% |
| Cash from Investing | 87.60% | 67.27% | 46.60% | 53.13% | -6,413.95% |
| Total Debt Issued | -- | -- | -- | 88.30% | -- |
| Total Debt Repaid | 90.19% | 79.58% | 64.77% | 64.77% | -259.18% |
| Issuance of Common Stock | 269.68% | -94.61% | -54.88% | -94.66% | 4.55% |
| Repurchase of Common Stock | -578.87% | 37.54% | 17.72% | -0.28% | 99.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -88.30% | -- |
| Cash from Financing | -109.94% | 57.65% | 53.39% | 39.14% | 256.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.07% | 137.97% | 298.14% | 261.37% | -331.99% |